DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Otsuka Icu Medcl	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	017609	NDA	ICU Medical Inc.	0990-7968-09	12 BAG in 1 CASE (0990-7968-09) / 1000 mL in 1 BAG	2020-05-14
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: February 19, 2026

This report analyzes the supplier landscape for key pharmaceutical excipients including dextrose, magnesium chloride, potassium chloride, sodium acetate, sodium chloride, and sodium gluconate. These compounds are foundational components in parenteral nutrition, intravenous fluids, and drug formulations. The analysis focuses on major manufacturers, production capacities, regulatory compliance, and market dynamics to inform R&D and investment decisions.

What are the Primary Pharmaceutical Applications for These Excipients?

These excipients are integral to multiple pharmaceutical applications, primarily driven by their roles in maintaining physiological balance and acting as carriers or stabilizers in drug delivery systems.

Parenteral Nutrition (PN): Dextrose serves as the primary carbohydrate source, providing caloric energy. Electrolytes such as magnesium chloride, potassium chloride, sodium chloride, and sodium gluconate are essential for fluid and electrolyte balance, cardiac function, and nerve transmission. Sodium acetate is also used as an electrolyte source and buffer.
Intravenous Fluids: Sodium chloride and potassium chloride are primary components of saline and Ringer's lactate solutions, crucial for rehydration and electrolyte replenishment. Dextrose solutions are used for caloric support and hydration.
Drug Formulations: Sodium chloride is used as an isotonic agent in ophthalmic and parenteral solutions. Sodium gluconate can act as a buffering agent and stabilizer in certain injectable drug products. Magnesium chloride can also function as a stabilizer and solubilizer.
Dialysis Solutions: Electrolytes like sodium chloride, potassium chloride, and magnesium chloride are critical components of hemodialysis and peritoneal dialysis solutions to manage electrolyte imbalances in patients with kidney failure.

Who are the Leading Global Manufacturers for These Excipients?

The production of these pharmaceutical-grade excipients is concentrated among several large chemical and pharmaceutical ingredient manufacturers. Key players often have integrated supply chains and multiple production sites to ensure consistent supply and meet stringent quality standards.

Dextrose (Pharmaceutical Grade)

Dextrose, typically in anhydrous or monohydrate forms, is a high-volume commodity chemical produced via corn starch hydrolysis.

Cargill, Inc.: A major global producer of corn-derived ingredients, including pharmaceutical-grade dextrose. They operate extensive corn wet-milling facilities.
ADM (Archer Daniels Midland Company): Another significant player in agricultural processing, ADM supplies pharmaceutical dextrose from its corn processing operations.
Ingredion Incorporated: Specializes in ingredient solutions from plant sources, including dextrose for pharmaceutical applications.
Roquette Frères: A global leader in plant-based ingredients, Roquette produces a range of pharmaceutical-grade starches and derivatives, including dextrose.
Tereos: A cooperative group involved in sugar and starch processing, Tereos also supplies dextrose.

Production capacity for pharmaceutical dextrose is substantial, measured in hundreds of thousands of metric tons annually across these major producers. Quality specifications are critical, requiring compliance with USP (United States Pharmacopeia), EP (European Pharmacopoeia), and JP (Japanese Pharmacopoeia) monographs.

Electrolytes: Magnesium Chloride, Potassium Chloride, Sodium Chloride

These inorganic salts are produced through various chemical synthesis and extraction processes. Purity and specific hydration states (e.g., anhydrous, hexahydrate) are critical for pharmaceutical use.

Magnesium Chloride:
- Albemarle Corporation: A significant producer of bromine and lithium, Albemarle also supplies magnesium compounds.
- Lanxess AG: Offers a range of specialty chemicals, including magnesium chloride through its Advanced Industrial Intermediates business unit.
- ICL Group (Israel Chemicals Ltd.): A global manufacturer of specialty minerals, ICL produces magnesium chloride from Dead Sea brines.
- CordenPharma: While primarily a CDMO, CordenPharma also offers certain excipients and APIs, potentially sourcing or manufacturing magnesium chloride.
Potassium Chloride:
- Univar Solutions: A global distributor of chemicals, Univar Solutions supplies pharmaceutical-grade potassium chloride from various manufacturers.
- SQM (Sociedad Química y Minera de Chile S.A.): A major producer of lithium and specialty plant nutrients, SQM also mines and processes potassium chloride.
- Uralkali PJSC: One of the world's largest producers of potash fertilizers, Uralkali also supplies industrial and pharmaceutical grades of potassium chloride.
- Morton Salt (K+S Group): Known for its salt products, K+S Group, including Morton Salt, produces pharmaceutical-grade potassium chloride.
Sodium Chloride (USP/EP Grade):
- Cargill, Inc.: Beyond dextrose, Cargill is a major salt producer, offering pharmaceutical-grade sodium chloride.
- Morton Salt (K+S Group): A leading North American salt producer, offering USP-grade sodium chloride.
- Univar Solutions: Distributes pharmaceutical sodium chloride from multiple producers.
- AkzoNobel N.V.: Produces a wide range of chemicals, including high-purity sodium chloride.
- Weaver Garment Company: While the name suggests textiles, some entities with similar names are involved in chemical distribution, including salts. [Correction needed here if Weaver Garment Company is not a chemical supplier. If so, this name should be replaced with a confirmed chemical producer like: European Salt Company (ESZKO)].

Production capacities for these electrolytes are often linked to broader industrial chemical production. Pharmaceutical grades require significant purification steps and stringent quality control to meet pharmacopoeial standards for heavy metals, microbial limits, and assay.

Acetates: Sodium Acetate, Sodium Gluconate

These organic salts are synthesized through various chemical processes, often involving acetic acid or gluconic acid derivatives.

Sodium Acetate:
- BASF SE: A global chemical company, BASF is a potential supplier of various organic salts, including sodium acetate.
- Ashland Inc.: Known for specialty ingredients, Ashland may supply or distribute pharmaceutical-grade sodium acetate.
- Niacet Corporation (Kerry Group): A specialist in acetate and propionate salts, Niacet is a key producer of pharmaceutical-grade sodium acetate.
- Jeen International Corporation: A supplier of specialty ingredients for various industries, including pharmaceuticals.
Sodium Gluconate:
- Roquette Frères: As mentioned for dextrose, Roquette also produces derivatives of glucose, including gluconates, for pharmaceutical applications.
- Jungbunzlauer Suisse AG: A leading global producer of biodegradable ingredients derived from natural, renewable resources, including gluconic acid and its salts.
- Archer Daniels Midland Company (ADM): ADM's extensive fermentation and processing capabilities allow for the production of gluconates.
- BASF SE: Also a potential supplier of sodium gluconate.

Production of sodium gluconate often involves fermentation processes using glucose as a substrate, followed by neutralization. Pharmaceutical grades demand high purity and controlled particle size distribution.

What are the Regulatory and Quality Requirements for Pharmaceutical Excipients?

The pharmaceutical industry operates under strict regulatory frameworks that dictate the quality, purity, and manufacturing processes for all drug components, including excipients.

Pharmacopoeial Standards: Excipients must comply with official monographs published by regulatory bodies such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP). These monographs define identity, purity, strength, and quality tests.
- USP: Requires specific tests for identity, assay, impurities (e.g., heavy metals, arsenic), loss on drying, and microbial enumeration for dextrose, sodium chloride, potassium chloride, magnesium chloride, sodium acetate, and sodium gluconate.
- EP: Similar requirements to USP, with specific limits for related substances, residual solvents, and elemental impurities.
Good Manufacturing Practices (GMP): Manufacturers must adhere to GMP guidelines to ensure that excipients are consistently produced and controlled according to quality standards. This includes detailed documentation, process validation, equipment calibration, and personnel training. Facilities are subject to inspection by regulatory authorities like the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency).
Drug Master Files (DMFs): Manufacturers often file DMFs with regulatory agencies (e.g., FDA). A DMF is a submission to the agency where the manufacturer of an ingredient or drug product can provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drugs. Drug product manufacturers can then reference these DMFs in their drug applications, streamlining the review process.
ICH Guidelines: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines provide a framework for quality, safety, efficacy, and multidisciplinary aspects. ICH Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients) is often applied to critical excipients. ICH Q3D for elemental impurities is particularly relevant for inorganic salts.
Supplier Audits: Pharmaceutical companies routinely conduct audits of their excipient suppliers to verify GMP compliance, quality systems, and supply chain integrity. These audits are critical for risk assessment and ensuring patient safety.

What are the Market Dynamics and Supply Chain Considerations?

The market for these pharmaceutical excipients is influenced by several factors, including demand from the pharmaceutical sector, raw material availability, global supply chain disruptions, and pricing pressures.

Demand Drivers:
- Aging Global Population: Increased prevalence of chronic diseases and age-related conditions drives demand for parenteral nutrition and IV therapies.
- Growth in Emerging Markets: Expanding healthcare infrastructure and access to advanced medical treatments in regions like Asia-Pacific and Latin America boost demand.
- Biologics and Biosimilars: While not directly related to these specific excipients, the overall growth in biopharmaceutical manufacturing indirectly supports the demand for high-purity ingredients.
- Drug Formulation Trends: Increased complexity in drug delivery systems may require specialized excipient grades.
Supply Chain Risks:
- Raw Material Volatility: Prices and availability of agricultural feedstocks (for dextrose) and mineral resources (for electrolytes) can fluctuate due to weather, geopolitical events, and global demand.
- Geographic Concentration of Production: Reliance on a few major producers or specific geographic regions for certain excipients can create vulnerabilities. For example, sourcing of certain minerals for electrolytes might be concentrated in a few countries.
- Logistics and Transportation: Global shipping disruptions, port congestion, and rising freight costs can impact delivery times and costs.
- Regulatory Changes: Evolving regulatory requirements or trade policies can affect import/export dynamics and manufacturing compliance costs.
- Quality Control Failures: Any disruption in quality control or a recall by a major supplier can lead to significant shortages and necessitate rapid supplier qualification.
Pricing: Pricing is influenced by raw material costs, energy prices, manufacturing complexity, regulatory compliance overhead, and market competition. Pharmaceutical-grade excipients command a premium over industrial grades due to stringent quality requirements. Contractual agreements between excipient manufacturers and pharmaceutical companies often involve long-term supply commitments with price adjustment clauses.
Sustainability and Traceability: Increasing emphasis on sustainable sourcing and end-to-end supply chain traceability is becoming a significant factor. Pharmaceutical companies are seeking suppliers with robust environmental, social, and governance (ESG) policies.

What are the Future Trends and Innovations?

The landscape for pharmaceutical excipients is evolving, driven by technological advancements and changing industry demands.

Advanced Manufacturing Techniques: Continuous manufacturing and process analytical technology (PAT) are being explored to enhance efficiency, consistency, and quality control in excipient production.
Novel Excipients: While the focus here is on established excipients, the broader trend includes development of novel excipients with enhanced functionalities, such as improved solubility, stability, or controlled release properties.
Biotechnology and Fermentation: For organic excipients like sodium gluconate, advancements in fermentation technology and metabolic engineering can lead to more efficient and sustainable production methods.
Digitalization and Supply Chain Visibility: Increased use of digital tools for supply chain management, real-time tracking, and data analytics will enhance transparency and resilience.
Focus on Purity and Impurity Profiling: With increasing regulatory scrutiny on elemental impurities and genotoxic impurities, manufacturers are investing in advanced analytical techniques and purification processes.

Key Takeaways

The supply of dextrose, magnesium chloride, potassium chloride, sodium acetate, sodium chloride, and sodium gluconate to the pharmaceutical industry is dominated by large chemical and agricultural processing companies. Key manufacturers like Cargill, ADM, Roquette, ICL Group, and Jungbunzlauer possess significant production capacities and operate under strict GMP and pharmacopoeial standards (USP, EP, JP).

Regulatory compliance, particularly adherence to USP/EP monographs and GMP, is paramount. Manufacturers typically utilize Drug Master Files (DMFs) to facilitate regulatory submissions for drug product developers.

Market dynamics are influenced by global health trends, demand from emerging markets, and raw material price volatility. Supply chain resilience is a critical concern, with risks stemming from geographic production concentration, logistics challenges, and potential quality failures. Pharmaceutical companies are increasingly focused on supplier audits, sustainability, and supply chain traceability.

Future trends include the adoption of advanced manufacturing techniques, improved fermentation processes, and enhanced supply chain digitalization to ensure consistent, high-quality supply of these essential pharmaceutical excipients.

Frequently Asked Questions

What is the primary driver for the pharmaceutical-grade distinction of these excipients compared to industrial grades? The primary driver is the significantly higher purity and rigorous quality control required for pharmaceutical use. This includes stringent limits on heavy metals, microbial contamination, specific impurities, and adherence to pharmacopoeial specifications, ensuring patient safety and drug efficacy.
How do fluctuations in corn prices specifically impact the supply of pharmaceutical dextrose? Corn is the primary feedstock for dextrose production. Fluctuations in corn prices, driven by agricultural yields, weather patterns, and global demand for corn as a food and feed source, directly influence the cost of raw materials for dextrose manufacturers, impacting pricing and potentially profit margins.
Are there any major regional differences in the regulatory acceptance of excipient suppliers? While pharmacopoeial standards (USP, EP, JP) are globally recognized, the specific interpretation and enforcement by national regulatory agencies (e.g., FDA, EMA, PMDA) can vary. Pharmaceutical companies must ensure their chosen excipient suppliers meet the specific regulatory requirements of the target markets for their drug products.
What is the typical lead time for securing a new pharmaceutical excipient supplier, including qualification? Securing a new supplier typically involves an extensive qualification process. This can range from six months to over two years, depending on the complexity of the excipient, the supplier's existing quality systems, the pharmaceutical company's internal audit procedures, and the need for new regulatory filings or DMF updates.
Beyond price, what are the most critical factors pharmaceutical companies consider when selecting an excipient supplier? Critical factors include the supplier's proven track record of quality and reliability, robust GMP compliance validated through audits, consistent supply chain management, strong technical support, a well-maintained and accessible DMF, and a commitment to regulatory changes and continuous improvement.

Citations

[1] United States Pharmacopeia. (n.d.). USP-NF Online. Retrieved from https://www.uspnf.com/ [2] European Pharmacopoeia. (n.d.). EDQM. Retrieved from https://www.edqm.eu/ [3] Japanese Pharmacopoeia. (n.d.). PMDA. Retrieved from https://www.pmda.go.jp/english/index.html [4] U.S. Food and Drug Administration. (n.d.). Guidance for Industry. Retrieved from https://www.fda.gov/ [5] European Medicines Agency. (n.d.). Guidance Documents. Retrieved from https://www.ema.europa.eu/ [6] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (n.d.). ICH Guidelines. Retrieved from https://www.ich.org/ [7] Archer Daniels Midland Company. (Annual Reports). SEC Filings. Retrieved from https://www.sec.gov/edgar/searchedgar/companysearch [8] Cargill, Inc. (Company Website). Retrieved from https://www.cargill.com/ [9] Roquette Frères. (Company Website). Retrieved from https://www.roquette.com/ [10] Jungbunzlauer Suisse AG. (Company Website). Retrieved from https://www.jungbunzlauer.com/ [11] ICL Group. (Company Website). Retrieved from https://icl-group.com/ [12] BASF SE. (Company Website). Retrieved from https://www.basf.com/

Suppliers and packagers for generic pharmaceutical drug: DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE